0 0 0 0 0 0 0 0
Sign Up Today X
Thanks for submitting the form.
Stockreport

A big Wall Street flip just changed the Regeneron narrative [Yahoo! Finance]

Regeneron Pharmaceuticals, Inc. (REGN)  More Company Research Source: Yahoo! Finance
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com
Bank of America Global Research raised its rating on Regeneron Pharmaceuticals. The firm said that its earlier worries regarding the company's main eye medicine had mostly been resolved and that new products and pipeline catalysts might change the stock's outlook over the next year. Bank of America revised its rating on Regeneron from "underperform" to "buy" and boosted its price target from $627 to $860. At the time of the article, Regeneron shares were worth $796.55, which means the revised target is nearly 8% higher. The call is about Eylea, Regeneron's long-term treatment for retinal illness, and more specifically, Eylea HD , the company's higher-dose version. Bank of America said it is now more hopeful that Eylea HD can perform better than what most people think it would, thanks to recent label modifications and what the company called helpful input from industry experts. In its note, the company succinctly expressed its shift in perspective: Bank of America said that it [Read more]
IMPACT SNAPSHOT EVENT TIME: REGN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
REGN alerts
from News Quantified
REGN
NEWS
REGN
Earnings
REGN
Analyst Actions
REGN
SEC Filings
Stockreport

A big Wall Street flip just changed the Regeneron narrative [Yahoo! Finance]

Regeneron Pharmaceuticals, Inc.  (REGN) 
More Company Research Source: Yahoo! Finance
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com
Bank of America Global Research raised its rating on Regeneron Pharmaceuticals. The firm said that its earlier worries regarding the company's main eye medicine had mostly been resolved and that new products and pipeline catalysts might change the stock's outlook over the next year. Bank of America revised its rating on Regeneron from "underperform" to "buy" and boosted its price target from $627 to $860. At the time of the article, Regeneron shares were worth $796.55, which means the revised target is nearly 8% higher. The call is about Eylea, Regeneron's long-term treatment for retinal illness, and more specifically, Eylea HD , the company's higher-dose version. Bank of America said it is now more hopeful that Eylea HD can perform better than what most people think it would, thanks to recent label modifications and what the company called helpful input from industry experts. In its note, the company succinctly expressed its shift in perspective: Bank of America said that it [Read more]
IMPACT SNAPSHOT
EVENT TIME:
REGN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS